Filter posts

A Discussion on Value at #BIF17

In a recent op-ed, BIO President and CEO Jim Greenwood wrote about a promising trend …

Insurer Shifting Blame for Rising Premiums

According to a new report from Chad Terhune with Kaiser Health News, insurance giant Anthem …

New Infographic: A Response to “A Better Deal” on Drug Pricing

The United States is the global leader in biomedical innovation, discovering more new cures than …

Three Encouraging Steps on Prescription Drug Costs

It’s a refrain you hear often in the news: Drug costs are soaring and nothing …

ICYMI: Jim Greenwood’s Letter in NYT on Drug Importation

Yesterday, the New York Times published a letter to the editor from BIO’s President and …